Literature DB >> 5359193

Oral contraceptives and urokinase activity.

H A Moses, R E Hardy, H M Frazier.   

Abstract

Mesh:

Substances:

Year:  1969        PMID: 5359193      PMCID: PMC2611809     

Source DB:  PubMed          Journal:  J Natl Med Assoc        ISSN: 0027-9684            Impact factor:   1.798


× No keyword cloud information.
  8 in total

1.  EFFECTS OF FEMALE HORMONES, USED AS ORAL CONTRACEPTIVES, ON THE FIBRINOLYTIC SYSTEM IN BLOOD.

Authors:  P BRAKMAN; T ASTRUP
Journal:  Lancet       Date:  1964-07-04       Impact factor: 79.321

2.  ORAL CONTRACEPTIVE HORMONES AND BLOOD COAGULABILITY.

Authors:  J M THOMSON; L POLLER
Journal:  Br Med J       Date:  1965-07-31

3.  The biochemistry and physiology of urokinase.

Authors:  D R CELANDER; M M GUEST
Journal:  Am J Cardiol       Date:  1960-08       Impact factor: 2.778

4.  Urokinase an activator of plasminogen from human urine. I. Isolation and properties.

Authors:  J PLOUG; N O KJELDGAARD
Journal:  Biochim Biophys Acta       Date:  1957-05

5.  Prostatic fibrinolysin; study of a case illustrating role in hemorrhagic diathesis of cancer of the prostate.

Authors:  H J TAGNON; P SCHULMAN; W F WHITMORE; L A LEONE
Journal:  Am J Med       Date:  1953-12       Impact factor: 4.965

6.  The fibrinolytic activity of urine.

Authors:  J R B WILLIAMS
Journal:  Br J Exp Pathol       Date:  1951-12

7.  Effects of low-dose oral contraceptives on blood coagulation.

Authors:  L Poller; A Tabiowo; J M Thomson
Journal:  Br Med J       Date:  1968-07-27

8.  CRYSTALLINE HUMAN UROKINASE: SOME PROPERTIES.

Authors:  A LESUK; L TERMINIELLO; J H TRAVER
Journal:  Science       Date:  1965-02-19       Impact factor: 47.728

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.